Experimental studies on the role of dopamine and glutamate in methamphetamine psycosis
Experimental studies on the role of dopamine and glutamate in methamphetamine psycosis
批准号:
05670796
负责人:
OHMORI Tetsuro
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1994
中文摘要
本研究通过一系列实验研究了谷氨酸在甲基苯丙胺(MA)行为和神经毒性效应中的作用。按递增剂量(2.5、5、7.5和10.0 mg/kg,sc,每天2次,分别于第1、3、5和7天)给药的大鼠表现出行为敏化。预处理与非竞争性(MK-801,0.5 mg/kg,ip)或竞争药物(D-CPP-ene,20 mg/kg,ip)NMDA拮抗剂在MA给药前阻止了行为敏化的发展。(5.0或7.5毫克/公斤,sc,2小时间隔)造成显着下降(40-60%的控制值)的DA在纹状体和5-HT在不同的脑区的水平。MK-801或D-CPP-ene预处理可防止DA和5-HT的这些降低。微透析研究表明,中毒剂量的MA显著增加纹状体谷氨酸的水平。一氧化氮(NO)合成酶抑制对MA诱导的行为和行为敏化的影响也进行了检查。一氧化氮合酶抑制剂N-硝基-L-精氨酸甲酯可显著降低小鼠的运动和刻板行为。此外,该抑制剂还能降低MA对类固醇刺激效应的致敏程度。这些结果表明,多巴胺能系统在MA诱导的行为致敏和神经毒性中起重要作用。
英文摘要
A series of experiments was conducted to examine the role of glutamate in the behavioral and neurotoxic effects of methamphetamine (MA). Rats treated with MA accoding to an escalating dose schedule (2.5,5,7.5 and 10.0 mg/kg, sc, twice a day on days 1,3,5 and 7, respectively) indicated behavioral sensitization. Pretreatment with either a noncompetitive (MK-801,0.5 mg/kg, ip) or a competitive (D-CPP-ene, 20 mg/kg, ip) NMDA antagonist prior to MA administration prevented the development of behavioral sensitization.On the other hand, rats treated with four injections of MA (5.0 or 7.5 mg/kg, sc, at 2 hr intervals) caused significant decrements (40-60% of control values) in levels of DA in the striatum and 5-HT in various brain regions. These decreases in DA and 5-HT were prevented by pretreatment with MK-801 or D-CPP-ene. Microdialysis studies revealed that the toxic dose of MA significantly increased levels of glutamate in the striatum.Effects of Nitric Oxide (NO) syntase inhibition on MA-induced behavior and behavioral sensitization were also examined. Nw-nitro-L-arginine methyl ester, an inhibitor of NO synthase, significantly decreased the level of locomotion and stereotypy. In addition, the inhibitor reduced the degree of sensitization to sterotypy stimulating effect of MA.These results suggest that the glutamatergic system plays an important role for MA-induced behavioral sensitization and neurotoxicity.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
小山 司: "覚醒剤の精神薬理-グルタミン酸系の関与を中心として-" 臨床精神医学. 23. 545-553 (1994)
Tsukasa Koyama:“兴奋剂的精神药理学 - 重点关注谷氨酸系统的参与 -”临床精神病学。 23. 545-553 (1994)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Ohmori: "Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine" Pharmacology, Biochemistry and Behavior. 48. 587-591 (1994)
T.Ohmori:“竞争性和非竞争性 NMDA 拮抗剂可阻断对甲基苯丙胺的敏感性”药理学、生物化学和行为。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Ohmori: "Scopolamine prerents the development of behavioral sensitization to methamphetamine" Life Sciences. (in press). (1995)
T.Ohmori:“东莨菪碱展示了对甲基苯丙胺行为敏感性的发展”生命科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Ohmori: "Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine" Pharmacology,Biochemistry and Behavior. (in press). (1994)
T.Ohmori:“竞争性和非竞争性 NMDA 拮抗剂可阻断对甲基苯丙胺的敏感性”药理学、生物化学和行为。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T.Abekawa: "Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens" Brain Research. 643. 276-281 (1994)
T.Abekawa:“重复施用高剂量甲基苯丙胺对大鼠纹状体和伏隔核中多巴胺和谷氨酸释放的影响”大脑研究。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 21 条
Establishment of biological marker and pathophysiological study of depression using omics analysis
-
批准号:18H02751
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2018
-
负责人:OHMORI Tetsuro
-
依托单位:
Effects of psychotropic drugs on the amino acid system in the brain: psychopharmacological application of high magnetic field MRS.
-
批准号:26461719
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2014
-
负责人:OHMORI Tetsuro
-
依托单位:
Clinical and neuroscientific study of schizophrenia with reference to cognitive function and QOL.
-
批准号:21591520
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:OHMORI Tetsuro
-
依托单位:
Evaluation of pharmacotherapy with reference to QOL and the analysis of therapeutic drug response.
-
批准号:16390325
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.91万
-
财政年份:2004
-
负责人:OHMORI Tetsuro
-
依托单位:
Behavioral and neurochemical studies on an animal model of schizophrenia.
-
批准号:09670968
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1997
-
负责人:OHMORI Tetsuro
-
依托单位:
Behavioral and neurochemical studies of schizophrenia using an animal model of the phychosis.
-
批准号:07671042
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1995
-
负责人:OHMORI Tetsuro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
石斛有效成分毛兰素靶向GGT7-GSH/Glutamate信号轴增强索拉非尼诱导的铁死亡逆转肝癌索拉非尼耐药的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:陈鹏
-
依托单位:
孕激素通过下丘脑Glutamate信号通路抑制LH峰的机制研究
-
批准号:82001502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘亚丽
-
依托单位:
BF区GABA-Glutamate-Ach神经微环路在麻醉-觉醒调控中的作用机制研究
-
批准号:81571351
-
项目类别:面上项目
-
资助金额:67.0万元
-
批准年份:2015
-
负责人:董海龙
-
依托单位:
穴位埋线调节围绝经期惊恐障碍患者脑神经活动Glutamate-GABA机制的在体研究
-
批准号:81473755
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:陈贵珍
-
依托单位: